The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Role of trastuzumab in infracentimetric HER2-positive breast cancer: The southern Italy experience.
Vincenzo Adamo
No relevant relationships to disclose
Giuseppina R. R. Ricciardi
No relevant relationships to disclose
Barbara Adamo
No relevant relationships to disclose
Michele Caruso
No relevant relationships to disclose
Hector J. Soto Parra
No relevant relationships to disclose
Carmelo Iacono
No relevant relationships to disclose
Angela Prestifilippo
No relevant relationships to disclose
Antonio Russo
No relevant relationships to disclose
Vittorio Gebbia
No relevant relationships to disclose
Nicolo Borsellino
No relevant relationships to disclose
Livio Blasi
No relevant relationships to disclose
Giuseppe Lavenia
No relevant relationships to disclose
Pietro Spadaro
No relevant relationships to disclose
Francesco Verderame
No relevant relationships to disclose
Giovanni Tuccari
No relevant relationships to disclose